Total Payments
$1.1M
2024 Payments
$98,532
Companies
12
Transactions
1,129
Medicare Patients
28
Medicare Billing
$1,876
Payment Breakdown by Category
Other$933,097 (84.4%)
Travel$111,171 (10.1%)
Food & Beverage$29,584 (2.7%)
Consulting$28,438 (2.6%)
Education$2,768 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $933,097 | 425 | 84.4% |
| Travel and Lodging | $111,171 | 316 | 10.1% |
| Food and Beverage | $29,584 | 371 | 2.7% |
| Consulting Fee | $28,438 | 9 | 2.6% |
| Education | $2,768 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $364,524 | 371 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $224,397 | 241 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $192,232 | 206 | $0 (2020) |
| ITI, Inc. | $150,944 | 132 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $58,209 | 74 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $54,544 | 40 | $0 (2019) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35,028 | 34 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $16,628 | 16 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $8,458 | 11 | $0 (2024) |
| ABBVIE INC. | $50.46 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98,532 | 111 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($35,028) |
| 2023 | $148,207 | 124 | ITI, Inc. ($57,145) |
| 2022 | $162,786 | 162 | Neurocrine BioSciences, Inc. ($73,011) |
| 2021 | $77,075 | 70 | ITI, Inc. ($34,059) |
| 2020 | $50,057 | 56 | Neurocrine Biosciences, Inc. ($29,730) |
| 2019 | $141,851 | 161 | Neurocrine Biosciences, Inc. ($91,635) |
| 2018 | $249,151 | 258 | Sunovion Pharmaceuticals Inc. ($95,630) |
| 2017 | $177,400 | 187 | Sunovion Pharmaceuticals Inc. ($89,408) |
All Payment Transactions
1,129 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $460.00 | General |
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $66.55 | General |
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $41.09 | General |
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $25.46 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,440.00 | General |
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $136.14 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $63.50 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: CNS | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,763.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $36.18 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $795.10 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $249.66 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $55.49 | General |
| 10/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Neuropsychiatry | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $121.47 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $84.05 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $877.50 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Central Nervous System | ||||||
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $94.87 | General |
| Category: Central Nervous System | ||||||
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $18.76 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 28 | 39 | $10,023 | $1,876 |
Total Patients
28
Total Services
39
Medicare Billing
$1,876
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 39 | $10,023 | $1,876 | 18.7% |
About Dr. Warren Ong, MD
Dr. Warren Ong, MD is a Psychiatry healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003896101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Ong, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $98,532 received in 2024. These payments were reported across 1,129 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($933,097).
As a Medicare-enrolled provider, Ong has provided services to 28 Medicare beneficiaries, totaling 39 services with total Medicare billing of $1,876. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Warwick, RI
- Active Since 01/17/2006
- Last Updated 11/26/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1003896101
Products in Payments
- INGREZZA (Drug) $364,524
- LATUDA (Drug) $192,232
- CAPLYTA (Drug) $185,972
- ABILIFY MAINTENA (Drug) $184,829
- Trintellix (Drug) $68,179
- AUSTEDO (Drug) $43,597
- ABILIFY ASIMTUFII (Drug) $16,599
- REXULTI (Drug) $15,303
- Austedo XR (Drug) $14,612
- ABILIFY MYCITE (Drug) $7,590
- COBENFY (Drug) $199.64
- Entyvio (Biological) $196.20
- TRINTELLIX (Drug) $121.75
- VRAYLAR (Drug) $50.46
- ARISTADA (Drug) $28.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Warwick
Dr. Ethan Kisch, M.d, M.D
Psychiatry — Payments: $74,541
Psychiatry $74,541
Dr. Terrie Mailhot, Md, MD
Psychiatry — Payments: $29,075
Psychiatry $29,075
Charles Denby, Md, MD
Psychiatry — Payments: $5,968
Psychiatry $5,968
James Gallo, Md, MD
Psychiatry — Payments: $5,708
Psychiatry $5,708
David Kroessler, Md, MD
Psychiatry — Payments: $3,857
Psychiatry $3,857
Dr. Alexander Scagnelli, M.d, M.D
Psychiatry — Payments: $2,626
Psychiatry $2,626